Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:92-98
Published online before print November 6, 2008, doi: 10.1161/ATVBAHA.108.174599
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
29/1/92    most recent
ATVBAHA.108.174599v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J. H.
Right arrow Articles by Duronio, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J. H.
Right arrow Articles by Duronio, V.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:92.)
© 2009 American Heart Association, Inc.


Cell Biology/Signaling

Oxidized LDL-Mediated Macrophage Survival Involves Elongation Factor-2 Kinase

Johnny H. Chen; Maziar Riazy; Ewan M. Smith; Christopher G. Proud; Urs P. Steinbrecher; Vincent Duronio

From the Department of Medicine (J.H.C., M.R., U.P.S., V.D.), University of British Columbia, and Vancouver Coastal Health Research Institute, Vancouver, BC, Canada; Genome Damage and Stability Centre (E.M.S.), University of Sussex, Falmer, Brighton, UK; and the School of Biological Sciences (C.G.P.), University of Southampton, UK.

Correspondence to Vincent Duronio, PhD, University of British Columbia, 2660 Oak Street, Vancouver, BC, V6H 3Z6, Canada. E-mail vduronio{at}interchange.ubc.ca

Objective— Macrophage survival and proliferation is believed to be a contributing factor in the development of early atherosclerotic lesions. Oxidized low density lipoprotein (oxLDL), a key mediator in the pathogenesis of this disease, has been shown to block apoptosis in macrophages deprived of growth factor. In this report, we investigate the mechanism of oxLDL-mediated macrophage survival.

Methods and Results— OxLDL, but not native LDL (nLDL), induces an immediate and oscillatory increase in intracellular calcium ([Ca2+]i). We also show that the calcium/calmodulin dependent kinase, eukaryotic elongation factor-2 kinase (eEF2 kinase), is activated in response to oxLDL, an effect that can be blocked by inhibiting calcium mobilization. Furthermore, selective inhibition of eEF2 kinase reverses the prosurvival effect of oxLDL and results in cellular apoptosis. p38 MAP kinase, a negative regulator of eEF2 kinase, is activated on growth factor withdrawal, a response that can be inhibited by oxLDL. Finally, we show that oxLDL, by activating eEF2 kinase, phosphorylates and therefore inhibits eEF2, resulting in an overall decrease in protein synthesis.

Conclusion— These results indicate a novel signaling pathway in which oxLDL can block macrophage apoptosis by mobilizing calcium and activating eEF2 kinase.


Key Words: oxidized LDL • eEF2 kinase • macrophage • apoptosis • calcium